ALABAstera Labs, Inc.
Is the price fair?
A demanding price: priced for a lot of growth and rich vs its sector.
Priced for ~40% a year FCF growth. The price already bakes in strong, sustained growth.
Sector median 30.5× across 203 covered peers. EV/EBIT counts debt as part of the price, so a cash-rich and a borrowed company can be compared on the same footing.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.
What ALAB's price assumes
Astera Labs, Inc. trades at 169× earnings against 76.7× for the median Semiconductors name, more expensive than its own group.
Trailing P/E · Semiconductors median 76.7 · 2.21× the median: the market pays up for this one
- Price / sales
- 80.0
Price / sales · today's price, fiscal year to Dec 31, 2025
- Free cash flow yield
- 0.41%
Free cash flow yield · Semiconductors median 1.8%
- Growth the price implies
- +40%
Growth the price implies · What free cash flow would have to do every year for a decade to justify today's price, discounted at 9.0%.
Details›
- Price / booktoday's price, fiscal year to Dec 31, 2025
- 50.0
- EV / EBITtoday's price, fiscal year to Dec 31, 2025
- 387
- EV / salestoday's price, fiscal year to Dec 31, 2025
- 78.6
- Technology median P/E459 names
- 37.7
- Semiconductors median P/E53 names
- 76.7
- Free cash flow, trailing twelve months
- $277M
- Market capitalisation
- $68.2B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.